Who are in the management team of Stoke Therapeutics, Inc.?

Jun 22 2025 10:39 PM IST
share
Share Via
As of March 2022, the management team of Stoke Therapeutics, Inc. includes Dr. Seth Harrison (Independent Chairman), Dr. Edward Kaye (CEO), and several Independent Directors: Ms. Jennifer Burstein, Prof. Adrian Krainer, Dr. Arthur Levin, Dr. Garry Menzel, and Ms. Julie Smith. They oversee the company's strategic direction and operations.
As of March 2022, the management team of Stoke Therapeutics, Inc. includes the following individuals:

- Dr. Seth Harrison, who serves as the Independent Chairman of the Board.
- Dr. Edward Kaye, who is the Chief Executive Officer and a Director.
- Ms. Jennifer Burstein, who is an Independent Director.
- Prof. Adrian Krainer, who is also an Independent Director.
- Dr. Arthur Levin, serving as an Independent Director.
- Dr. Garry Menzel, who is an Independent Director.
- Ms. Julie Smith, another Independent Director.

This team is responsible for guiding the company's strategic direction and operations.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News